F. Landoni

Latest

• Copy number alterations in stage I epithelial ovarian cancer highlight three genomic patterns associated with prognosis
• Genome-wide copy-number alterations in circulating tumor DNA as a novel biomarker for patients with high-grade serous ovarian cancer
• Multisite analysis of high-grade serous epithelial ovarian cancers identifies genomic regions of focal and recurrent copy number alteration in 3q26.2 and 8q24.3